Free Trial

Anthem (NASDAQ:ANTX) Downgraded to "Sell" Rating by Wall Street Zen

Anthem logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen downgraded Anthem (NASDAQ:ANTX) from a "hold" to a sell, and Weiss Ratings began coverage with a "sell (d-)", while MarketBeat shows one Buy and one Sell leading to an average rating of Hold and an average price target of $2.00.
  • Anthem shares recently opened at $4.34 with a 52-week range of $1.00–$6.91 and a market cap of $156.24 million; the company reported -$0.29 EPS for the last quarter and analysts forecast about -0.91 EPS for the year.
  • Five stocks to consider instead of Anthem.

Anthem (NASDAQ:ANTX - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a research report issued to clients and investors on Saturday.

Separately, Weiss Ratings assumed coverage on Anthem in a report on Tuesday, April 7th. They set a "sell (d-)" rating for the company. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $2.00.

Get Our Latest Stock Report on Anthem

Anthem Stock Performance

Shares of NASDAQ ANTX opened at $4.34 on Friday. Anthem has a 52 week low of $1.00 and a 52 week high of $6.91. The stock has a market capitalization of $156.24 million, a P/E ratio of -3.74 and a beta of -1.31. The stock's fifty day moving average is $3.09 and its 200 day moving average is $1.83.

Anthem (NASDAQ:ANTX - Get Free Report) last issued its quarterly earnings results on Tuesday, March 17th. The company reported ($0.29) EPS for the quarter. Equities research analysts forecast that Anthem will post -0.91 earnings per share for the current year.

Anthem Company Profile

(Get Free Report)

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Anthem Right Now?

Before you consider Anthem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anthem wasn't on the list.

While Anthem currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines